The chart above plots the price of DBD over the range selected — one day to the full history — drawn by TradingView from their own data. Our own licensed end-of-day series holds 42 sessions over that window: $79.48 on 26 May 2026 through $89.40 on 24 July 2026.
Market cap$3.0B
P/E (TTM)44.3
52-week range$53.94 – $89.40
Avg volume61.1K
Finazon · prior-day close · valuation computed from SEC EDGAR filings · as of Aug 20, 2026
DBD insider trades
SEC Form 4 · last 90 days · newest reported trade 31 Jul 2026
Open-market buys3
Open-market sells8
Net sold$49.90M
Non-trade filings1
DateInsiderTypeSharesValue
31 Jul 2026Timko Thomas SEVP, CFOBuy700$51K
26 Jun 2026Millstreet Capital Management LLC10% OwnerSell100,000$8.48M
25 Jun 2026Millstreet Capital Management LLC10% OwnerSell2,741$233K
24 Jun 2026Millstreet Capital Management LLC10% OwnerSell228,723$19.20M
15 Jun 2026Millstreet Capital Management LLC10% OwnerSell1,765$148K
12 Jun 2026Millstreet Capital Management LLC10% OwnerSell159,675$13.11M
11 Jun 2026Millstreet Capital Management LLC10% OwnerSell1,108$91K
10 Jun 2026Millstreet Capital Management LLC10% OwnerSell17,660$1.45M
08 Jun 2026Millstreet Capital Management LLC10% OwnerSell88,334$7.33M
27 May 2026Marquez OctavioPresident and CEOBuy621$49K
26 May 2026Marquez OctavioPresident and CEOBuy629$50K
Compensation mechanics
Share grants, option exercises, tax withholding and transfers. They reach the same Form 4 as a trade, but they are not the insider buying or selling on the open market, so no purchase or sale value applies to them.
DateInsiderTypeSharesValue
03 Jun 2026Timko Thomas SEVP, CFOGift672
DBD reported financials
SEC EDGAR XBRL
DBD reported revenue of $3.8B for the fiscal year ended 31 Dec 2025. Net income over the same period was $94.6M.
FigureReportedPeriod
Revenue
$3.8B
31 Dec 2025 fiscal year
Net income
$94.6M
31 Dec 2025 fiscal year
Diluted EPS
$2.54
31 Dec 2025 fiscal year
Total assets
$3.7B
30 Jun 2026 at period end
Total equity
$969.2M
30 Jun 2026 at period end
Source: SEC EDGAR XBRL company facts · latest period ended 30 Jun 2026
DBD earnings
SEC EDGAR
DatePeriodEPSRevenue
30 Jun 2026Q2 2026$0.44$931M
31 Mar 2026Q1 2026$0.14$892M
31 Dec 2025FY 2025$2.54$3.81B
30 Sep 2025Q3 2025$1.11$945M
30 Jun 2025Q2 2025$0.33$915M
31 Mar 2025Q1 2025$-0.22$841M
31 Dec 2024FY 2024$-0.44$3.75B
30 Sep 2024Q3 2024$-0.60$927M
Next report no date announced in SEC filings yet
Reported figures & scheduled dates · SEC EDGAR filings
DBD institutional holders
SEC Form 13F
8 of the 45 institutional funds we track reported a DBD position for the quarter ended 30 Jun 2026 — a combined $33.3M; the latest of those filings landed 14 Aug 2026.